These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8921529)
21. Corticobasal degeneration as a cognitive disorder. Graham NL; Bak TH; Hodges JR Mov Disord; 2003 Nov; 18(11):1224-32. PubMed ID: 14639661 [TBL] [Abstract][Full Text] [Related]
22. Neuropathological diagnosis of progressive supranuclear palsy and related disorders. Ikeda K; Akiyama H J Neuropathol Exp Neurol; 1996 Dec; 55(12):1278-9. PubMed ID: 8957452 [No Abstract] [Full Text] [Related]
28. The many faces of corticobasal degeneration. Wadia PM; Lang AE Parkinsonism Relat Disord; 2007; 13 Suppl 3():S336-40. PubMed ID: 18267261 [TBL] [Abstract][Full Text] [Related]
29. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Boeve BF; Lang AE; Litvan I Ann Neurol; 2003; 54 Suppl 5():S15-9. PubMed ID: 12833363 [No Abstract] [Full Text] [Related]
30. [Corticobasal degeneration. Description of a consanguineous case]. Giroud Benítez JL; Alvarez González E; Alvarez González L Rev Neurol; 2001 Nov 16-30; 33(10):999. PubMed ID: 11785021 [No Abstract] [Full Text] [Related]
31. [An autopsy case of corticobasal degeneration without prominent cortical pathology--an imitator of progressive supranuclear palsy]. Hattori M; Yoshida M; Ojika K; Yuasa H; Mitake S; Hashizume Y Rinsho Shinkeigaku; 2000 Apr; 40(4):372-7. PubMed ID: 10967656 [TBL] [Abstract][Full Text] [Related]
32. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. Bergeron C; Pollanen MS; Weyer L; Lang AE J Neuropathol Exp Neurol; 1997 Jun; 56(6):726-34. PubMed ID: 9184663 [TBL] [Abstract][Full Text] [Related]
33. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. Tuite PJ; Clark HB; Bergeron C; Bower M; St George-Hyslop P; Mateva V; Anderson J; Knopman DS Arch Neurol; 2005 Sep; 62(9):1453-7. PubMed ID: 16157754 [TBL] [Abstract][Full Text] [Related]
34. Argyrophilic grains are reliable disease-specific features of corticobasal degeneration. Tatsumi S; Mimuro M; Iwasaki Y; Takahashi R; Kakita A; Takahashi H; Yoshida M J Neuropathol Exp Neurol; 2014 Jan; 73(1):30-8. PubMed ID: 24335531 [TBL] [Abstract][Full Text] [Related]
35. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy. Shiozawa M; Fukutani Y; Sasaki K; Isaki K; Hamano T; Hirayama M; Imamura K; Mukai M; Arai N; Cairns NJ Clin Neuropathol; 2000; 19(4):192-9. PubMed ID: 10919351 [TBL] [Abstract][Full Text] [Related]
37. [P300 findings in patients with corticobasal degeneration]. Homma A; Harayama H; Kondo H; Sato M; Saito Y; Hayashi T; Soma Y; Tsuji S No To Shinkei; 1996 Oct; 48(10):925-9. PubMed ID: 8921531 [TBL] [Abstract][Full Text] [Related]
38. Discrepancy between tau immunoreactivity and argyrophilia by the Bodian method in neocortical neurons of corticobasal degeneration. Uchihara T; Mizusawa H; Tsuchiya K; Kondo H; Oda T; Ikeda K Acta Neuropathol; 1998 Dec; 96(6):553-7. PubMed ID: 9845283 [TBL] [Abstract][Full Text] [Related]